Browse Categories
Search
Stay In Touch
Login
|
|
Home > All Products > Pharmaceutical Executive: Reports, Surveys & Trends (2007)
Pharmaceutical Executive: Reports, Surveys & Trends (2007)
List Price: $79.95
Price: $59.95
You Save: $20.00 (25 %)
|
Item Number: PHYZ107
FORECAST 2007
Regulatory changes, legal challenges, the on going search for a new business model—and how to deal with $80 billion worth of patent expirations. Analysis and commentary from top experts and the Pharm Exec editorial team.
2007 Forecast: Grab a life vest
8TH ANNUAL SALES FORCE SURVEY
How is pharma dealing with the dwindling profitability of their sales reps? This survey benchmarks sales force size, reps' incentives, and their changing responsibilities.
Sales execs are struggling to redefine their rep-comp plans. This annual survey reveals the hard numbers.
SALES FORCE QUALITY
It's not only what your reps do, it's how they do it that counts. This second annual ranking offers an insightful view of the industry's leading sales organizations and why they're on top.
TargetRX Which company has the most effective sales force? The Answer-and the reasons why-may surprise you.
PHARM EXEC 50
This industry bible ranks the world's top companies by prescription drug sales, R&D spend, top products, and much more.
Our eighth annual ranking of the world's top 50 pharma companies with: complete listing of top 50 pharmas by sales Top 10 products of 2006 Top R & D spending by firm
MEDIA SPEND TRENDS
Where are companies investing their marketing dollars?
This editorial package includes up-to-date stats on professional and DTC advertising. Plus, a special focus on how companies are marketing their brands online.
DTC lives on one decade later. And while more pharmas are spending more online, TV still reigns supreme
DRUG DELIVERY
Pharm Exec profiles the pipeline and the market to bring you the drug-delivery technologies that are changing the field of medicine.
The science of tomorrow is taking shape today. We place our bets on the therapies that will transform healthcare in the decades to come.
INDUSTRY AUDIT + COMPANY OF THE YEAR
One of our most popular features, the audit ranks pharma companies on more than a dozen key metrics to identify the year’s top performers. This is one not to miss.
St. Joseph's University Pharm Exec's sixth annual review of the top publicly traded companies. Plus, 2007's corporate kudos.
IN PLAY: PHAST AND PHURIOUS
Pharma's on an M&A spree, snapping up small pharmas and biotechs. This article identifies the hottest targets (and the likeliest buyers).
Companies' futures are being decided in today's sell or be-sold merger market. We offer our deal picks, and the companies to watch in the coming years.
4TH ANNUAL PIPELINE REPORT
The best of drugs in development, as selected by leading clinicians, top financial analysts, and other experts.
A roundup of the most exciting products just about to drop into the sea of drugs.
|
|
|
|